Home/Filings/4/0000899243-22-027418
4//SEC Filing

Larue Catherine 4

Accession 0000899243-22-027418

CIK 0001596946other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 5:36 PM ET

Size

12.5 KB

Accession

0000899243-22-027418

Insider Transaction Report

Form 4
Period: 2022-07-31
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-07-31+6,91740,294 total
  • Exercise/Conversion

    Restricted Stock Units

    2022-07-316,9176,917 total
    Ordinary Shares (6,917 underlying)
Holdings
  • Ordinary Share Option (Right to Buy)

    Exercise: $4.81Exp: 2030-09-01Ordinary Shares (20,790 underlying)
    20,790
  • Ordinary Share Option (Right to Buy)

    Exercise: $4.55Exp: 2030-10-31Ordinary Shares (13,611 underlying)
    13,611
  • Ordinary Share Option (Right to Buy)

    Exercise: $4.81Exp: 2030-09-01Ordinary Shares (2,171 underlying)
    2,171
  • Ordinary Share Option (Right to Buy)

    Exercise: $2.53Exp: 2031-10-31Ordinary Shares (24,040 underlying)
    24,040
Footnotes (6)
  • [F1]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F2]6,930 options vested on September 1, 2021 and remain exercisable, and the remaining 13,860 options will vest in two equal installments on September 1, 2022 and September 2, 2023.
  • [F3]724 options vested on October 31, 2021 and remain exercisable, and the remaining 723 options will vest on October 31, 2022.
  • [F4]All 13,611 options have vested and remain exercisable.
  • [F5]On October 31, 2021, the Reporting Person was granted 27,668 restricted stock units, of which 20,751 have vested and have converted into ordinary shares. The remaining 6,917 restricted stock units will vest on October 31, 2022.
  • [F6]The options vest and become exercisable on October 31, 2022.

Issuer

Quotient Ltd

CIK 0001596946

Entity typeother

Related Parties

1
  • filerCIK 0001823057

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 5:36 PM ET
Size
12.5 KB